[1]Kim JY，Kim MH，Lee TY，et al．Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma：a prospective study compared with conventional imaging．Am J Gastroenterol，2008，103（5）：1145-1151．

[2]Seo S，Hatano E，Higashi T，et al．Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis，P-glycoprotein expression，and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma．Surgery，2008，143（6）：769-777.

[3]Moon CM，Bang S，Chung JB，et al．Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas．J Gastroenterol Hepatol，2008，23（5）：759-765．

[4]Kim YJ，Yun M，Lee WJ，et al．Usefulness of ¹⁸F-FDG PET in intrahepatic cholangiocarcinoma．Eur J Nucl Med Mol Imaging，2003，30（11）：1467-1472．

[5]Ramos-Font C，Santiago Chinchilla A，Rodríguez- Fernández A，et al．Gallbladder cancer staging with ¹⁸F-FDG PET-CT（in Spanish）．Rev Esp Med Nucl，2009，28（2）：74-77．

[6]Petrowsky H，Wildbrett P，Husarik DB，et al．Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma．J Hepatol，2006，45（1）：43-50．

[7]Corvera CU，Blumgart LH，Akhurst T，et al． ¹⁸F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer．J Am Coll Surg，2008，206（1）：57-65．

[8]Ishak K，Anthony PP，Sobin LH．Histological typing of tumours of the liver．2nd ed．World Health Organization International Histological Classification of Tumours．Springer，1994．

[9]Sonin LH．Histological classification of tumours．New York：Springer，1994．

[10]Jadvar H，Henderson RW，Conti PS．[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography：computed tomography in recurrent and metastatic cholangiocarcinoma．J Comput Assist Tomogr，2007，31（2）：223-228．

[11]Lee JD，Yang WI，Park YN，et al．Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic massforming cholangiocarcinoma with increased（18）F-FDG uptake．J Nucl Med，2005，46（10）：1753-1759．

[12]Kluge R，Schmidt F，Caca K，et al．Positron emission tomography with [（18）F]fluoro-2-deoxy-Dglucose for diagnosis and staging of bile duct cancer．Hepatology，2001，33（5）：1029-1035．

[13]Anderson CD，Rice MH，Pinson CW，et al．Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma．J Gastrointest Surg，2004，8（1）：90-97．

[14]Nakeeb A，Pitt HA，Sohn TA，et al．Cholangiocarcinoma：a spectrum of intrahepatic，perihilar，and distal tumors．Ann Surg，1996，224（4）：463-473．

[15]Li J，Kuehl H，Grabellus F，et al．Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/ CT．J Surg Oncol，2008，98（6）：438-443．